Review on recent advances in cellulose nanofibril based hybrid aerogels: Synthesis, properties and their applications.

With the depletion of fossil fuels and growing environmental concerns, the modernized era of technology is in desperate need of sustainable and eco-friendly materials. The industrial sector surely has enough resources to produce cost-effective, renewable, reusable, and sustainable raw materials. The family of very porous solid materials known as aerogels has a variety of exceptional qualities, such as high porosity, high specific surface area, ultralow density, and superior thermal, acoustic, and dielectric properties. As a result, aerogels have the potential to be used for many different purposes, such as absorbents, supercapacitors, energy storage, and catalytic supports. Recently, cellulose nanofibril (CNF) aerogels have attracted remarkable attention for their large-scale utilization because of their high absorption capacity, low density, biodegradability, large surface area, high porosity, and biocompatibility. Recent advancements have confirmed that CNF-based hybrid aerogels can be proposed as the most privileged and promising novel material in various applications. This comprehensive review highlights the recent reports of the CNF-based hybrid aerogels, including their properties and frequent preparation approaches, in addition to their new applications in the areas of fire retardant, water and oil separation, supercapacitors, environmental, and CO2 capture. It is also assumed that this article will promote additional investigation and establish innovative capabilities to enhance novel CNF-based hybrid aerogels with new and exciting applications.

Unravelling the Molecular Mechanisms of a Quercetin Nanocrystal for Treating Potential Parkinson's Disease in a Rotenone Model: Supporting Evidence of Network Pharmacology and In Silico Data Analysis.

The prevalence of Parkinson's disease places a significant burden on society; therefore, there is an urgent need to develop more effective drugs. However, the development of these drugs is both expensive and risky. Quercetin (QUE) has potent pharmacological effects on neurodegenerative diseases, but its low solubility in water and poor bioavailability limit its use in pharmaceutical applications. In this study, Quercetin nanocrystals (QNC) were synthesized and compared to standard QUE. A network-pharmacology-based methodology was applied, including target prediction, network construction, a gene ontology (GO) analysis, a KEGG pathway enrichment analysis, and molecular docking. This study aimed to identify the targets of QUE relevant to the treatment of Parkinson's disease and investigate the associated pharmacological mechanisms. Most of the predicted targets are involved in dopamine uptake during synaptic transmission. QUE regulates the key targets DRD2 and DRD4, which significantly affect dopaminergic synapses. The molecular docking results showed that QUE had a better binding affinity than the standard drug l-Dopa. From these experiments, it can be concluded that QNC effectively reduced the adverse effects caused by rotenone-induced oxidative stress in biochemical, neurochemical, and histopathological alterations. Therefore, QNC can potentially treat Parkinson's disease, and its effectiveness should be assessed in future clinical trials.